-
Development of potent PLA2 inhibitors to target PRDX6, a novel host based malaria drug target Position A 2-year postdoctoral position is available in the Unité de Biologie de Plasmodium et Vaccins
-
This 2-year, full-time postdoc, starting January 2027 (or as soon as possible thereafter), is part of a French National Research Agency (ANR) funded project, UniGEM (Unified Inference for Genomic
-
models. Current treatment strategies for HBV are life-long and rarely curative. Finite antiviral and immunomodulatory therapeutic strategies are being pursued for an HBV functional cure to treat the 254
-
responses induced in antigen presenting cells, and the differentiation of specific B and T cells will be evaluated by spectral flow cytometry and scRNAseq, while CD4+ T cell / B cell interactions will be
-
models, flow cytometry, confocal microscopy and unbiased approaches such as single cells transcriptomics, spatial transcriptomics and epigenetics to characterize molecular and cellular mechanisms. Using
-
that match with the overall goals of the unit can be discussed at the interview stage and can be adapted to the individual progress of the candidate throughout his/her tenure in the unit. The unit offers the
-
.2209936120 . Applications (a motivation letter, a full CV and minimum of two references) should be sent to Ivo G Boneca ([email protected] ).
-
& Duration: This position is available in October 2026 for a minimum of 2 years, renewable. Location: The Institut Pasteur (https://www.pasteur.fr/en) is a world-renowned center of excellence for its research
-
molecular phylogenetics. Previous work on protein sequence data focusing on viruses. Previous work on protein structure predictions. ✏️Post details 1-year position with likely renewal to up to 3 years (2-year
-
Paris, Mai 2026 A 2-year, post-doctoral position is available in the Guermonprez lab at Institut Pasteur Paris (“Dendritic cells and adaptive immunity” Unit, Immunology Department https